经导管主动脉瓣置换术后的最佳抗栓策略：“少即是多”的理念总是更好吗？ - Suppr

Suppr

超能文献

Optimal Antithrombotic Strategy After Transcatheter Aortic Valve Replacement: Is the "Less Is More" Concept Always Better?

作者信息

Ko Euihong, Park Duk-Woo

机构信息

Division of Cardiology Asan Medical Center University of Ulsan College of Medicine Seoul Korea.

出版信息

J Am Heart Assoc. 2021 May 4;10(9):e021241. doi: 10.1161/JAHA.121.021241. Epub 2021 Apr 17.

DOI:10.1161/JAHA.121.021241

PMID:33870701

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8200736/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbbe/8200736/8f2e4db8ed24/JAH3-10-e021241-g001.jpg

相似文献

Optimal Antithrombotic Strategy After Transcatheter Aortic Valve Replacement: Is the "Less Is More" Concept Always Better?经导管主动脉瓣置换术后的最佳抗栓策略：“少即是多”的理念总是更好吗？

J Am Heart Assoc. 2021 May 4;10(9):e021241. doi: 10.1161/JAHA.121.021241. Epub 2021 Apr 17.

Coronary Angiography Challenges After Transcatheter Aortic Valve Replacement-in-Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后冠状动脉造影的挑战——在经导管主动脉瓣置换术中

J Am Heart Assoc. 2020 Jul 7;9(13):e017409. doi: 10.1161/JAHA.120.017409. Epub 2020 Jun 24.

Is an antithrombotic strategy after transcatheter aortic valve implantation clearer now?经导管主动脉瓣植入术后的抗栓策略现在更明确了吗？

J Thromb Thrombolysis. 2021 Nov;52(4):1160-1164. doi: 10.1007/s11239-021-02473-9. Epub 2021 May 24.

Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update.经导管主动脉瓣植入术后的抗栓药物治疗：最新进展

Expert Rev Cardiovasc Ther. 2019 Jul;17(7):479-496. doi: 10.1080/14779072.2019.1632189. Epub 2019 Jun 24.

Antithrombotic After TAVR: No Treatment, No Problem?经导管主动脉瓣置换术后的抗栓治疗：不治疗，就没问题？

JACC Cardiovasc Interv. 2023 Jan 9;16(1):92-93. doi: 10.1016/j.jcin.2022.11.003. Epub 2022 Dec 14.

"Subclinical" Leaflet Thrombosis in Transcatheter Aortic Valve Implantation: A Latent Risk?经导管主动脉瓣植入术中的“亚临床”瓣叶血栓形成：一种潜在风险？

Rev Esp Cardiol (Engl Ed). 2017 Jun;70(6):512-514. doi: 10.1016/j.rec.2016.08.007. Epub 2016 Oct 1.

Antithrombotic therapy following transcatheter aortic valve intervention.经导管主动脉瓣介入治疗后的抗血栓治疗。

Pharmacol Ther. 2023 Oct;250:108509. doi: 10.1016/j.pharmthera.2023.108509. Epub 2023 Aug 11.

Sex, Antithrombotics, and Outcomes After TAVR: Is There More Difference Within Sexes or Between Them?经导管主动脉瓣置换术后的性别、抗栓药物与预后：性别内部还是性别之间存在更多差异？

JACC Cardiovasc Interv. 2023 May 8;16(9):1103-1106. doi: 10.1016/j.jcin.2023.03.051.

Antithrombotic Therapy for Transcatheter Valvular Interventions: A Revisit.经导管瓣膜介入治疗的抗血栓治疗：再探。

Curr Vasc Pharmacol. 2018 Jan 26;16(2):107-113. doi: 10.2174/1570161115666170406105753.

Direct Oral Anticoagulants Versus Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Trials.经导管主动脉瓣置换术后直接口服抗凝剂与抗血小板治疗的比较：随机试验的荟萃分析

Circ Cardiovasc Interv. 2022 Sep;15(9):e012194. doi: 10.1161/CIRCINTERVENTIONS.122.012194. Epub 2022 Sep 6.

引用本文的文献

Transcatheter Aortic Valve Replacement in Asia: Present Status and Future Perspectives.亚洲经导管主动脉瓣置换术：现状与未来展望

JACC Asia. 2021 Dec 7;1(3):279-293. doi: 10.1016/j.jacasi.2021.10.006. eCollection 2021 Dec.

Procedural outcomes in patients with dual versus single antiplatelet therapy prior to transcatheter aortic valve replacement.经导管主动脉瓣置换术治疗前双联与单联抗血小板治疗患者的程序结局。

Sci Rep. 2021 Jul 29;11(1):15415. doi: 10.1038/s41598-021-94599-2.

本文引用的文献

Duration of Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement: Systematic Review and Network Meta-Analysis.经导管主动脉瓣置换术后抗血小板治疗的持续时间：系统评价和网络荟萃分析。

J Am Heart Assoc. 2021 May 4;10(9):e019490. doi: 10.1161/JAHA.120.019490. Epub 2021 Apr 17.

Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk.低手术风险患者经导管主动脉瓣置换术后 2 年的结果。

J Am Coll Cardiol. 2021 Mar 9;77(9):1149-1161. doi: 10.1016/j.jacc.2020.12.052.

Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement.ADAPT-TAVR试验的原理与设计：依度沙班与双联抗血小板治疗预防经导管主动脉瓣置换术后瓣叶血栓形成和脑栓塞的随机对照研究

BMJ Open. 2021 Jan 5;11(1):e042587. doi: 10.1136/bmjopen-2020-042587.

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020美国心脏病学会/美国心脏协会瓣膜性心脏病患者管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告

Circulation. 2021 Feb 2;143(5):e72-e227. doi: 10.1161/CIR.0000000000000923. Epub 2020 Dec 17.

Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.经导管主动脉瓣置换术后阿司匹林联合或不联合氯吡格雷

N Engl J Med. 2020 Oct 8;383(15):1447-1457. doi: 10.1056/NEJMoa2017815. Epub 2020 Aug 30.

Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy.经导管和外科生物瓣叶亚临床血栓形成：PARTNER 3 心脏计算机断层扫描子研究。

J Am Coll Cardiol. 2020 Jun 23;75(24):3003-3015. doi: 10.1016/j.jacc.2020.04.043.

Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.经导管主动脉瓣置换术后联合或不联合氯吡格雷的抗凝治疗。

N Engl J Med. 2020 Apr 30;382(18):1696-1707. doi: 10.1056/NEJMoa1915152. Epub 2020 Mar 29.

Late Cerebrovascular Events Following Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后的迟发性脑血管事件。

JACC Cardiovasc Interv. 2020 Apr 13;13(7):872-881. doi: 10.1016/j.jcin.2019.11.022. Epub 2020 Mar 11.

Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement.经导管主动脉瓣置换术后瓣叶活动度降低。

N Engl J Med. 2020 Jan 9;382(2):130-139. doi: 10.1056/NEJMoa1911426. Epub 2019 Nov 16.

A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.经导管主动脉瓣置换术后利伐沙班的对照试验。

N Engl J Med. 2020 Jan 9;382(2):120-129. doi: 10.1056/NEJMoa1911425. Epub 2019 Nov 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验